The Armenian Reporter13h
Cullinan Associates Inc. Sells 1,600 Shares of Boston Scientific Co. (NYSE:BSX)
Cullinan Associates Inc. reduced its position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 5.5% during the ...
The Armenian Reporter13h
Calamos Wealth Management LLC Buys 872 Shares of Boston Scientific Co. (NYSE:BSX)
Calamos Wealth Management LLC grew its stake in Boston Scientific Co. (NYSE:BSX – Free Report) by 0.6% during the 4th quarter ...
TMCnet18h
Supernus Announces FDA Approval of ONAPGOâ„¢ (apomorphine hydrochloride) for Parkinson's Disease
USE ONAPGO is a prescription medicine used to treat motor fluctuations (OFF episodes) in adults with advanced Parkinson’s disease (PD). It is not known if ONAPGO is safe and effective in children.
Supernus Pharmaceuticals, Inc.: Supernus Announces FDA Approval of ONAPGO (apomorphine hydrochloride) for Parkinson's Disease
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...